David Klatzmann
David Klatzmann
Sorbonne University & Pitié-Salpêtrière Hospital
Verified email at sorbonne-universite.fr
Cited by
Cited by
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
D Klatzmann, E Champagne, S Chamaret, J Gruest, D Guetard, ...
Nature 312 (5996), 767-768, 1984
Isolation of a new human retrovirus from West African patients with AIDS
F Clavel, D Guetard, F Brun-Vezinet, S Chamaret, MA Rey, ...
Science 233 (4761), 343-346, 1986
Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes
D Klatzmann, F Barre-Sinoussi, MT Nugeyre, C Danquet, E Vilmer, ...
Science 225 (4657), 59-63, 1984
Natural regulatory T cells control the development of atherosclerosis in mice
H Ait-Oufella, BL Salomon, S Potteaux, AKL Robertson, P Gourdy, J Zoll, ...
Nature medicine 12 (2), 178-180, 2006
CD4+ CD25+ immunoregulatory T cells
JL Cohen, A Trenado, D Vasey, D Klatzmann, BL Salomon
The Journal of experimental medicine 196 (3), 401, 2002
Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis
D Saadoun, M Rosenzwajg, F Joly, A Six, F Carrat, V Thibault, D Sene, ...
New England Journal of Medicine 365 (22), 2067-2077, 2011
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.
P Sonigo, M Alizon, K Staskus, D Klatzmann, S Cole, O Danos, E Retzel, ...
Cell 42 (1), 369, 1985
Continuous Activation of Autoreactive CD4+ CD25+ Regulatory T Cells in the Steady State
S Fisson, G Darrasse-Jèze, E Litvinova, F Septier, D Klatzmann, R Liblau, ...
The Journal of experimental medicine 198 (5), 737-746, 2003
Recipient-type specific CD4 CD25 regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia
A Trenado, F Charlotte, S Fisson, M Yagello, D Klatzmann, BL Salomon, ...
J Clin Invest 112 (11), 1688-1696, 2003
Regression of established macroscopic liver metastases after in situ transduction of a suicide gene
M Caruso, Y Panis, S Gagandeep, D Houssin, JL Salzmann, D Klatzmann
Proceedings of the National Academy of Sciences 90 (15), 7024, 1993
Epidermal Langerhans cells-a target for HTLV-III/LAV infection
E Tschachler, V Groh, M Popovic, DL Mann, K Konrad, B Safai, L Eron, ...
Journal of investigative dermatology 88 (2), 233-237, 1987
A novel dendritic cell subset involved in tumor immunosurveillance
J Taieb, N Chaput, C Ménard, L Apetoh, E Ullrich, M Bonmort, ...
Nature medicine 12 (2), 214-219, 2006
Dendritic cells are required for the development of chronic eosinophilic airway inflammation in response to inhaled antigen in sensitized mice
BN Lambrecht, B Salomon, D Klatzmann, RA Pauwels
The Journal of Immunology 160 (8), 4090-4097, 1998
Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice
M Sudres, F Norol, A Trenado, S Grégoire, F Charlotte, B Levacher, ...
The Journal of Immunology 176 (12), 7761, 2006
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases
D Klatzmann, AK Abbas
Nature Reviews Immunology 15 (5), 283-294, 2015
IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells
Y Grinberg-Bleyer, A Baeyens, S You, R Elhage, G Fourcade, S Gregoire, ...
Journal of Experimental Medicine 207 (9), 1871-1878, 2010
Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy …
RA Dewey, G Morrissey, CM Cowsill, D Stone, F Bolognani, NJF Dodd, ...
Nature medicine 5 (11), 1257, 1999
A phase I/II study of herpes simplex virus type 1 thymidine kinase “suicide” gene therapy for recurrent glioblastoma
D Klatzmann, CA Valery, G Bensimon, B Marro, O Boyer, K Mokhtari, ...
Human gene therapy 9 (17), 2595-2604, 1998
Heterogeneity of mouse spleen dendritic cells: in vivo phagocytic activity, expression of macrophage markers, and subpopulation turnover
PJM Leenen, K Radosevic, JSA Voerman, B Salomon, N van Rooijen, ...
The Journal of Immunology 160 (5), 2166-2173, 1998
Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
A Hartemann, G Bensimon, CA Payan, S Jacqueminet, O Bourron, ...
The lancet Diabetes & endocrinology 1 (4), 295-305, 2013
The system can't perform the operation now. Try again later.
Articles 1–20